HLS Therapeutics Inc
TSX:HLS
HLS Therapeutics Inc
Depreciation & Amortization
HLS Therapeutics Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
HLS Therapeutics Inc
TSX:HLS
|
Depreciation & Amortization
$29.5m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
19%
|
|
M
|
Manitex Capital Inc
XTSX:MNX
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is HLS Therapeutics Inc's Depreciation & Amortization?
Depreciation & Amortization
29.5m
USD
Based on the financial report for Mar 31, 2024, HLS Therapeutics Inc's Depreciation & Amortization amounts to 29.5m USD.
What is HLS Therapeutics Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
19%
Over the last year, the Depreciation & Amortization growth was -14%. The average annual Depreciation & Amortization growth rates for HLS Therapeutics Inc have been -3% over the past three years , -2% over the past five years , and 19% over the past ten years .